Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Lantheus misled investors about blockbuster imaging agent, class action lawsuit claims
Plaintiff attorneys claim the Massachusetts-based company shattered the competitive position of Pylarify, a PET imaging agent for prostate cancer.
American College of Radiology touts key imaging provisions in House spending bill
"We urge Congress to pass final legislation that reflects this approach and retains ACR-backed provisions that can save lives," CEO Dana Smetherman, MD, MPH, MBA, said Sept. 10.
GE HealthCare to acquire Alzheimer’s imaging AI firm Icometrix
Founded in 2011 and based in Belgium, the AI firm offers the first software for automating brain assessments needed to administer disease therapies from Biogen and Eli Lilly.
Internet searches reveal skyrocketing interest in POCUS implementation
New data align with a rise in intrigue around bedside point-of-care ultrasound to address growing patient demand.
ASNC calls on members to fight 57% Medicare cut for cardiac amyloid imaging
Jamieson M. Bourque, MD, MHS, president-elect of the American Society of Nuclear Cardiology, shared the group's concerns with Cardiovascular Business. “This is going to have a highly negative impact," he said.

‘Name your price’ tool brings affordable imaging to underinsured

New York-based healthcare startup Medmo may upend the imaging market with its new platform that allows consumers to name their own price for medical imaging tests such as MRIs or CT scans.

No more surprise billing? Startup lets patients name their own prices for imaging services

A new healthcare startup, New York City-based Medmo, has launched a platform that allows patients to name their own price for various imaging services, including MRIs and CT scans.

Recall issued for antihypertensive drug over cancer concerns

Valsartan, a common drug used to control hypertension and heart failure, is being recalled in 22 counties due to concerns its active pharmaceutical ingredient, N-Nitrosodimethylamine (NDMA), a known carcinogen, poses a cancer risk.

RSNA Research & Education Foundation will award $4M in grants in 2018

The Radiological Society of North America (RSNA) Research and Education (R&E) Foundation will award $4 million in radiology research and education grants this year, spanning 54 different institutions.

RSNA R&E Foundation awarding $4M in funding in 2018

The RSNA Research and Education (R&E) Foundation announced Wednesday, July 11, that it is awarding $4 million in grants in 2018.

Video game company raises $12.7M for breast cancer research in 2 weeks

Blizzard Entertainment, an Irvine, California-based video game company, announced this week that it has raised $12.7 million for the Breast Cancer Research Foundation during its Pink Mercy charity campaign.

USPSTF: Evidence insufficient to assess benefits, harms of using ABI to screen for PAD

The U.S. Preventive Services Task Force (USPSTF) issued a Grade I recommendation for screening peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI), indicating current evidence is insufficient to recommend screening without signs or symptoms of disease.

Radiology Partners announces partnership with West Houston Radiology

Radiology Partners has announced a new partnership with West Houston Radiology in Houston.

Economics

Lantheus misled investors about blockbuster imaging agent, class action lawsuit claims

American College of Radiology touts key imaging provisions in House spending bill

GE HealthCare to acquire Alzheimer’s imaging AI firm Icometrix

Internet searches reveal skyrocketing interest in POCUS implementation

ASNC calls on members to fight 57% Medicare cut for cardiac amyloid imaging